When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions Compounded "semaglutide" is not FDA approved semaglutide.com The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Rapid 250mcg Pure Prescriptions BPC 157 and the Difference Between an Evidence Gap and a Cover Up: What the entire human evidence base actually looks like, and the questions to ask next. WellFounded Founders Health &